Aquestive Therapeutics, Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Aquestive Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Aquestive Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was 62.9 %, a 468% increase year-over-year.
  • Aquestive Therapeutics, Inc. annual Return On Equity for 2023 was 7.4 %, a 85.9% decline from 2022.
  • Aquestive Therapeutics, Inc. annual Return On Equity for 2022 was 52.3 %, a 54% decline from 2021.
  • Aquestive Therapeutics, Inc. annual Return On Equity for 2021 was 114 %, a 35.1% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 7.4 -44.9 -85.9% Jan 1, 2023 Dec 31, 2023
2022 52.3 -61.4 -54% Jan 1, 2022 Dec 31, 2022
2021 114 -61.6 -35.1% Jan 1, 2021 Dec 31, 2021
2020 175 -196 -52.8% Jan 1, 2020 Dec 31, 2020
2019 372 -511 -57.9% Jan 1, 2019 Dec 31, 2019
2018 882 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.